Figure 1.
Response to HBI0101 therapy. Best ORR (A), PFS (B), DOR in HBI0101 responders (C), and OS (D) were estimated in the first consecutive 50 patients dosed with 800 × 106 CAR+ cells. sCR/CR (dark/light blue); VGPR (dark/light green); PR (dark/light yellow); MRD positive, light colors; MRD negative, dark colors. DOR, duration of response.